Effects of tamoxifen on uterus

P Neven, S M Ismail, T. Bourne, X. De Muylder, William P. Collins, Y Van Belle, R CAMPO, Stuart Campbell, G. Vanderick, T.J. Powles, Patrick Neven, Yves Van Belle, Rudi Campo, Zenon Rayter, J.-C. Gazet, John Shephed, P. A. Trott, W. E. Svensson, Roger A’Hern
The Lancet · 1994 · vol. 344(8922) , pp. 622–624 · doi:10.1016/s0140-6736(94)92013-3 · PMID:7914997 · W2098644676
Other OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This paper investigates the effects of tamoxifen on the uterus, detailing its impact on uterine tissue and cellular processes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Endometrial Hyperplasia Tamoxifen Endometrial Hyperplasia Endometrial Hyperplasia Female Humans Tamoxifen

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (14)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:59:07.256998+00:00
unpaywall
last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0 · commercial use OK